Human medicines European public assessment report (EPAR): Adakveo, crizanlizumab, Anemia, Sickle Cell, Date of authorisation: 28/10/2020, Revision: 6, Status: Withdrawn

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023

Referral: Hydroxyprogesterone-containing medicinal products, hydroxyprogesterone, associated names: Lentogest,Progesterone Retard Pharlon,Proluton Depot, Article 31 referrals, Procedure started, 29/09/2023

Template: Declaration for the risk management plan (RMP) publication

Template for submission of comments for the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Call for comments on the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)

Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products

Multi-stakeholder workshop on Real World Data (RWD) quality and Real World Evidence (RWE) use, European Medicines Agency and online, from 26/06/2023 to 27/06/2023

Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) dataload friendly file including deprecated terms

Combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products